GOLDLINE PHARMACEUTICAL SHARE PRICE

Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company in the name of `Goldline Pharmaceutical Private Limited` with the Registrar of Companies, Mumbai. Subsequently, Company was converted into a public limited Company and the name of Company was changed to `Goldline Pharmaceutical Limited` w.e.f. September 23, 2013. Company is engaged in the business of marketing pharmaceutical products under the Goldline brand. Their products are divided into five categories: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Valiente. The pharmaceutical products marketed under the "Goldline" brand are not manufactured by Company. Instead, they enter into contractual arrangements with third-party manufacturers, who produce the products based on market research, demand analysis, and specifications. Presently, Company maintain contractual arrangements with 15 manufacturers and 7 distributors, ensuring a stable supply chain and consistent market presence. Company extend comprehensive material supply and procurement support to hospitals and healthcare partners. Through the promoter group entities as Numerius Healthcare Pvt Ltd & Activista Healthcare Pvt Ltd, Company manage trading and supply chain operations, thereby ensuring reliable procurement, seamless distribution, and logistical efficiency. Company is planning the Initial Public Offer of 30,00,000 Equity Shares having the face value of Rs 10 each through Fresh Issue.

Goldline Pharmaceutical share price as on 12 Jun 2026 is Rs. 46.5. Over the past 6 months, the Goldline Pharmaceutical share price has increased by 0% and in the last one year, it has decreased by 18.09%. The 52-week low for Goldline Pharmaceutical share price was Rs. 41.76 and 52-week high was Rs. 60.

Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company in the name of `Goldline Pharmaceutical Private Limited` with the Registrar of Companies, Mumbai. Subsequently, Company was converted into a public limited Company and the name of Company was changed to `Goldline Pharmaceutical Limited` w.e.f. September 23, 2013. Company is engaged in the business of marketing pharmaceutical products under the Goldline brand. Their products are divided into five categories: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Valiente. The pharmaceutical products marketed under the "Goldline" brand are not manufactured by Company. Instead, they enter into contractual arrangements with third-party manufacturers, who produce the products based on market research, demand analysis, and specifications. Presently, Company maintain contractual arrangements with 15 manufacturers and 7 distributors, ensuring a stable supply chain and consistent market presence. Company extend comprehensive material supply and procurement support to hospitals and healthcare partners. Through the promoter group entities as Numerius Healthcare Pvt Ltd & Activista Healthcare Pvt Ltd, Company manage trading and supply chain operations, thereby ensuring reliable procurement, seamless distribution, and logistical efficiency. Company is planning the Initial Public Offer of 30,00,000 Equity Shares having the face value of Rs 10 each through Fresh Issue.

Goldline Pharmaceutical share price as on 12 Jun 2026 is Rs. 46.5. Over the past 6 months, the Goldline Pharmaceutical share price has increased by 0% and in the last one year, it has decreased by 18.09%. The 52-week low for Goldline Pharmaceutical share price was Rs. 41.76 and 52-week high was Rs. 60.